Brief: Autolus Therapeutics Announces Collaboration With Bristol Myers Squibb For Use Of Autolus’ Proprietary Safety Switch System
04/10/2022 12:13
Oct 4 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS ANNOUNCES COLLABORATION WITH BRISTOL
MYERS
SQUIBB FOR USE OF AUTOLUS’ PROPRIETARY SAFETY SWITCH SYSTEM
* AUTOLUS THERAPEUTICS PLC - BRISTOL MYERS SQUIBB TO RECEIVE
ACCESS TO AUTOLUS' RQR8 SAFETY SWITCH FOR USE IN CELL THERAPY
PROGRAMS
* AUTOLUS THERAPEUTICS - CO TO RECEIVE UPFRONT PAYMENT, WITH
POTENTIAL FOR NEAR TERM OPTION EXERCISE FEES & DEVELOPMENT
MILESTONE PAYMENTS PLUS ROYALTIES
Source text for Eikon: ID:nGNX8nXCBn
Further company coverage: AUTL.O
(Reuters.Briefs@thomsonreuters.com;)
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants